NCT07155590
Subphenotype- and Complication-guided Adjunctive Fosfomycin Therapy for Staphylococcus Aureus Bacteraemia
Track this trial
Free. We email you which fields changed when ClinicalTrials.gov updates this record.
Record History
All 3 versions: 3 with changes below. See every version on ClinicalTrials.gov ↗
- Notable Eligibility criteria expanded, about 15 words
- Trial completed
- Collaborators: details revised at 1 of 4 entries
- Publications: details revised at 1 of 1 entry
- Minor Site details revised at 1 of 2 sites
- Study title shortened, about 6 words
- Study First Submitted
- Notable: the plan changed
- Minor: routine updates
Endpoints
Primary
All-cause mortality at 60 days
Timeframe: At 60 days from randomisation
Secondary (2)
All-cause mortality at 30 days
Treatment success at 8 weeks
Arms and interventions
Adjunctive fosfomycin therapy
Patients with Staphylococcus aureus bacteraemia from the BACSAFO cohort treated with any regimen including fosfomycin
Monotherapy
Patients with Staphylococcus aureus bacteraemia from the BACSAFO cohort treated with any regimen not containing fosfomycin
Sites
2 sites in 1 country